Professionals 518 results
- Mathilde Lefranc-Barthe
- Partner of W&S SELAS
- +33 1 53 64 82 63
- vCard
Partner of W&S SELAS
Capabilities 90 results
Practice Area
Industry
Experience 148 results
Experience
|February 4, 2026
Experience
|February 2, 2026
Experience
|January 8, 2026
$2.75 Billion Constellation Energy Generation, LLC Public Offering of Senior Notes
Insights & News 3,990 results
Seminar/CLE
|March 25, 2026
Sanctions, Arbitration, and Cross-Border Enforcement: Complex Intersections in Practice
Webinar
|March 19, 2026
New Perspectives on Venezuela: On-the-Ground Insights and Direct Foreign Investment Outlook
Client Alert
|March 9, 2026
|3 Min Read
On January 27, 2026, the U.S. Department of Health and Human Services Office of Inspector General (the OIG) issued a Special Advisory Bulletin (the Bulletin) addressing the application of the federal anti-kickback statute (the AKS) to direct-to-consumer (DTC) prescription drug sales.
The Bulletin, the OIG’s first Special Advisory Bulletin since September 2014, was issued in response to the proliferation of DTC programs. The Bulletin, which sets forth the framework under which a manufacturer’s DTC program presents a low risk of violating the AKS, is viewed by the growing DTC industry as favorable guidance. DTC programs offering modern weight-loss medications, such as GLP-1 drugs, are becoming increasingly popular, and the Bulletin provides a helpful framework to support the viability of these programs.
Other Results 72 results
Law Glossary
What Is Privacy Compliance Law?
Site Content
Law Glossary


